About Parasuram Melarcode Krishnamoorthy
Dr. Parasuram Melarcode Krishnamoorthy is the Inaugural Director of Structural Heart Program, Director of Interventional Cardiology Fellowship and an Associate Professor of Medicine at the University of Oklahoma Health Sciences Medical Center. Prior to joining OU Health, Dr. Krishnamoorthy served as the Associate Director of Structural Heart Program at the Mount Sinai Hospital in New York City for five years. Dr. Krishnamoorthy is an interventional cardiologist with specialized clinical focus in complex percutaneous coronary and structural heart interventions, particularly transcatheter aortic, mitral, tricuspid valve therapies, LAAO and ASD/PFO closure. He has performed over 2000 cases of complex coronary interventions, 1000 cases of transcatheter aortic valve replacement (TAVR), and over 350 transcatheter mitral valve repair (transcatheter edge-to-edge repair) (TEER with MitraClip, Pascal), transcatheter tricuspid valve repair (TEER with TriClip), and transcatheter mitral and tricuspid valve replacement procedures, with excellent clinical outcomes. Dr. Krishnamoorthy has enrolled patients in several multicenter clinical trials in aortic, mitral and tricuspid valve disease. He participated in TRILUMINATE (Tricuspid clip) trial since 2019 and one of the early adopters of intracardiac echocardiography (ICE) in structural heart procedures. He along with his team performed one of the first cases of triclip in the country after its commercial approval in April 2024.
His clinical research focus is on lifetime management of aortic stenosis, particularly redo transcatheter aortic valve interventions, and role of advanced imaging in structural heart disease. His research efforts have been published in many high impact journals, and he has published over 140 peer-reviewed manuscripts, abstracts, and book chapters. He is a regularly invited faculty and a lecturer at national and international conferences, including TCT, SCAI, CRT, New York Valves and London Valves. He is a reviewer in many cardiology journals and grades abstract for TCT, CRT and SCAI Annual Scientific Sessions. He has received several awards for clinical excellence, research and medical education, including the Dr. Madhukar Deshmukh Young Investigator award by the American Association of Cardiologists of Indian Origin, SCAI 30 in Their 30s award, and CRT Young Leadership Award. Dr. Krishnamoorthy has also demonstrated a deep commitment to quality improvement through digital technology. He played a vital role in the development of STEMICathAID, a novel HIPAA-compliant mobile application designed to improve outcomes in patients with STEMI and cardiogenic shock through adherence to AHA Mission: Lifeline guidelines. Dr. Krishnamoorthy actively contributes to the Society for Cardiovascular Angiography and Interventions through serving on multiple committees and councils, including the Ischemic Heart Disease Council and the Quality Improvement Committee.
Dr. Krishnamoorthy is well known among his patients for providing “concierge care.” He collaborates with a multidisciplinary group of interventional cardiologists, cardiac surgeons, imaging specialists, heart failure specialists, electrophysiologists, vascular surgeons and interprofessional staff to offer comprehensive, holistic care in patients with complex valve disease. He is board-certified in internal medicine, cardiovascular disease, interventional cardiology, comprehensive adult echocardiography, and Nuclear cardiology. As the clinical partner of the University of Oklahoma, our physicians regularly conduct research. To view all of Dr. Krishnamoorthy's publications, visit his profile on the National Library of Medicine.
